Goblet cell carcinoid tumours of the appendix: A unique neuroendocrine tumour

Histopathology

Volumn 52, Issue 6, 2008, Pages 770-771

  Chetty, R ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 20; CYTOKERATIN 7;

APPENDIX TUMOR; CARCINOID; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; GOBLET CELL; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; LETTER; MITOSIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SMALL CELL CARCINOMA;

APPENDICEAL NEOPLASMS; APPENDIX; CARCINOID TUMOR; HUMANS;

EID: 42649093466     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03024.x     Document Type: Letter

References (7)

1. van Eeden S, Offerhaus GJA, Hart AAM et al. Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology 2007 51 763 773.
2. Oberndorfer S. Karzinoide tumoren des Dunndarms. Frankf Z Pathol. 1907 1 425 432.
3. Alsaad KO, Serra S, Schmitt A, Perren A, Chetty R. Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix. Endocr. Pathol. 2007 18 16 22.
4. Alsaad KO, Serra S, Perren A, Hsieh E, Chetty R. CK19 and CD99 immunoexpression profile in goblet cell (mucin-producing neuroendocrine tumors) and classical carcinoids of the vermiform appendix. Int. J. Surg. Pathol. 2007 15 252 257.
5. Ali A, Serra S, Asa SL, Chetty R. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am. J. Surg. Pathol. 2006 30 1588 1594.
6. Schmitt AM, Anlauf M, Rousson V et al. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am. J. Surg. Pathol. 2007 31 1677 1682.
7. Stancu M, Wu TT, Wallace C et al. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal tumors. Mod. Pathol. 2003 16 1189 1198.